A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease - Test2 - elhamkhani - TriplyDB

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

http://www.wikidata.org/entity/Q34989806

about

Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy Differential Fasting Plasma Glucose and Ketone Body Levels in GHRKO versus 3xTg-AD Mice: A Potential Contributor to Aging-Related Cognitive Status?Ketogenic diets: from cancer to mitochondrial diseases and beyond.Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE(-/-) mice: implications for Alzheimer's disease.Novel ketone diet enhances physical and cognitive performance Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats.Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.Ketone bodies mimic the life span extending properties of caloric restriction.Neuroketotherapeutics: A modern review of a century-old therapy.Ketogenic Diet and Cancer-a Perspective.β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease.Strategies to Improve Adherence to Dietary Weight Loss Interventions in Research and Real-World Settings.Effects of a ketogenic diet on hippocampal plasticity in freely moving juvenile rats Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?Exploring the Association between Alzheimer's Disease, Oral Health, Microbial Endocrinology and Nutrition.Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.β-Hydroxybutyrate Boosts Mitochondrial and Neuronal Metabolism but is not Preferred Over Glucose Under Activated Conditions.Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate.Additional mechanisms for brain activation failure due to reduced glucose metabolism-a commentary on Zilberter and Zilberter: The vicious circle of hypometabolism in neurodegenerative diseases.Direct Production of (R)-3-Hydroxybutyric Acid of High Optical Purity by Halomonas sp. OITC1261 Under Aerobic conditions.Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.How Can a Ketogenic Diet Improve Motor Function?The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review.Anxiolytic Effect of Exogenous Ketone Supplementation Is Abolished by Adenosine A1 Receptor Inhibition in Wistar Albino Glaxo/Rijswijk Rats.Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease.Coconut oil - a nutty idea?The Expanding Role of Ketogenic Diets in Adult Neurological Disorders

P2860

Q26740087-212E2701-10AC-4602-ABBC-7B75F590FC28 Q28069398-D4444EF8-F336-44DD-84CB-0154B4586F06 Q33790607-0AB32ECA-34D5-4520-A799-7A505BDF50AC Q34509699-6AC03577-F17F-4E28-A8C1-77EA57552AA6 Q37075513-76962F55-DE47-4245-B5A8-432243E21A6B Q37400125-35594165-2DCF-495C-BF61-1B08C30B9B48 Q37403736-96407EC6-F36D-4E93-8480-200727CFE21A Q37475036-6643F3A9-1121-4F71-8F15-D5975DE04709 Q38400509-CD6368D1-B4DA-4B2B-970D-84230208DECA Q38696404-D37C94E8-D2BD-4E7A-860B-37D1EE394715 Q38735813-55B26C0D-7294-4D40-9776-A0068F4255FC Q38745984-6B462DE0-CD12-4FF0-8608-E6C89248D769 Q38936285-E6A460EC-9B5D-406C-8EF5-2F9A4EA21C60 Q39003451-478CED1A-F65D-4902-90E9-BE7B69300E14 Q39428145-64F3EA03-B375-440D-8FA4-85F7C1F896A7 Q39428310-21D22BF2-8A53-404A-B634-A87E608414AD Q42530746-7C2FE142-A4D8-4809-8C81-10F024EB0BAA Q45824470-5DAB900C-ED34-4D09-AAA3-86CDB0327335 Q46237947-8879B14D-4C8A-45B0-BC94-55CEC6FF478F Q46646567-87271015-37D0-43CD-A0A1-124027E74812 Q46770261-879950E5-82EB-4D5E-AF01-93E294B9D802 Q47640970-92F3198D-70C6-4876-BBAC-7BA809EB6073 Q47990556-AF8C79BA-7917-4A85-A108-098371D61C91 Q48217851-5C46D1C8-7B7E-4903-899F-91119BB0AFAA Q48351368-717A84DD-26C3-466B-8E3E-83DBB56F34E5 Q49620553-65CDA8A4-AB3D-4151-9142-571ACF259675 Q52632503-A562D152-BA09-4594-9D22-D815E50B4230 Q53838781-DB4851C7-A829-4AB0-B11E-38E543A110E5 Q55114436-650048E3-F43E-4A8E-86FB-3642874462B1 Q55362028-73A13F94-00CB-41F1-A1C7-1720280D4024 Q56172740-02BC6B4B-22F0-426C-A2F1-9873EB741460 Q58795119-BB628765-2CE0-4917-B216-4DC95068B2B9

P2860

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

http://www.wikidata.org/entity/Q34989806

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@ast

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@en

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@nl

type

label

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@ast

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@en

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@nl

prefLabel

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@ast

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@en

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@nl

P1433

Q34989806-9A53B78A-F2C4-467E-AD41-BF32F71C26E1

P1476

Q34989806-BC2BE433-A880-4B9A-B3A0-041A65CDCD0D

P2093

Q34989806-2A7DEAD5-4E86-45C9-86F0-E24BD1A9043D

Q34989806-5AB4A5D4-6A25-4E34-A8F1-B38787884FD5

Q34989806-6231E512-FECA-4A10-BB29-5450D4272959

Q34989806-8C37BC7B-A985-42E9-9E87-4EF54A8C91BF

Q34989806-D7EE78FA-776B-4FAF-B9A7-AA2519B5DF10

P2860

Q34989806-21C26262-1F66-4BFC-8511-5B05BD7B5C06

Q34989806-3833FFCF-06E6-4204-96B0-4A3E24B6A0A6

Q34989806-3EB72A1D-E6F1-4B6D-B6E6-967E5631015F

Q34989806-41C6FB32-EB3F-44F5-A35F-84D6D59D5E6E

Q34989806-4FF45824-0F33-4DAD-80C5-11AA5ECA3B05

Q34989806-57BDF8CE-F05F-4BC9-91EB-AE7C890AE865

Q34989806-57C8AC66-75FF-40F8-9E69-A0AD2A1969EF

Q34989806-62A15F53-6382-49C8-A7F1-ED2430657513

Q34989806-647D7631-5A60-4521-9E74-F83B7886AAEC

Q34989806-7BFA37D2-A54A-45A5-8586-1A1CAC6615BB

P304

Q34989806-E29237A7-B20A-410B-A467-9DE3A24D281A

P31

Q34989806-4A0F0FB8-0E16-47EC-B81A-7495022E1A4F

P356

Q34989806-B466981C-5B8B-448C-A50F-9C15E9D18E69

P433

Q34989806-567B98C6-5568-4E7E-BFA7-0DA77E3DB65E

P478

Q34989806-EBBB60AE-C12F-457A-98F6-9CA4A32F6FEF

P577

Q34989806-B2811CBE-FB22-488E-B806-43F720783AFC

P698

Q34989806-0D29637E-58CB-43BB-A04C-1BA3A7275DB5

P932

Q34989806-BBC80F41-EA4D-4744-886A-2BDA3C90D7DE

P356

J.JALZ.2014.01.006

P1433

Alzheimer's and Dementia

P1476

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

@en

P2093

Mary T Newport

http://www.w3.org/2001/XMLSchema#string

Michael Todd King

http://www.w3.org/2001/XMLSchema#string

Richard L Veech

http://www.w3.org/2001/XMLSchema#string

Theodore B VanItallie

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Kashiwaya

http://www.w3.org/2001/XMLSchema#string

P2860

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Fasting: the history, pathophysiology and complications.

Brain metabolism during fasting

Brain fuel metabolism, aging, and Alzheimer's disease

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease

Clinical efficacy of the ketogenic diet.

Regulation of mammalian pyruvate dehydrogenase.

Ketone bodies, potential therapeutic uses.

Dietary ketosis enhances memory in mild cognitive impairment.

P304

99-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2014.01.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25301680

http://www.w3.org/2001/XMLSchema#string

P932

4300286

http://www.w3.org/2001/XMLSchema#string